Affimed Therapeutics (AFMD) PT Lowered to $10 at Laidlaw

July 3, 2019 8:28 AM EDT
Get Alerts AFMD Hot Sheet
Price: $6.56 +5.98%

Rating Summary:
    10 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 8 | New: 36
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Laidlaw analyst Yale Jen lowered the price target on Affimed Therapeutics (NASDAQ: AFMD) to $10.00 (from $15.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change